Sunday - June 29, 2025

Graphite One

Medical Cannabis Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 6.10
0.00 0.00
0
17.33M
US$ 105.710M
US$ 1.30
0.00 0.00
0
53.94M
US$ 70.120M
US$ 0.12
0.00 0.00
0
290.12M
US$ 35.100M
US$ 0.25
0.00 0.00
0
138.96M
US$ 34.740M
US$ 0.71
0.00 0.00
0
44.00M
US$ 31.240M
US$ 0.05
-0.004 -7.55
14,500
447.68M
US$ 21.940M
US$ 0.05
-0.0008 -1.54
5,000
411.12M
US$ 20.970M
US$ 0.03
0.00 0.00
0
541.70M
US$ 13.540M
US$ 2.65
-0.14 -4.86
113,592
3.09M
US$ 8.170M
US$ 0.05
0.009 23.68
237
169.74M
US$ 7.980M
US$ 0.04
0.0035 9.59
112,539
184.26M
US$ 7.370M
US$ 0.02
0.00 0.00
0
403.26M
US$ 6.090M
US$ 0.02
0.00 0.00
0
328.70M
US$ 5.030M
US$ 0.02
0.00 0.00
0
163.94M
US$ 4.020M
US$ 0.03
0.0036 13.14
240
125.43M
US$ 3.890M
US$ 0.005
0.0012 31.58
27,500
490.47M
US$ 2.450M
US$ 1.45
0.00 0.00
70,447
1.43M
US$ 2.070M
US$ 0.004
0.00 0.00
0
308.39M
US$ 1.230M
US$ 0.21
-0.02 -8.26
101
3.07M
US$ 648K
US$ 0.0009
0.00 0.00
0
423.36M
US$ 381K
US$ 0.0087
0.00 0.00
0
38.91M
US$ 339K
US$ 0.001
0.00 0.00
0
147.69M
US$ 148K
US$ 0.00
-0.0002 -100.00
42.70M
5.84B
US$ -
US$ 0.00
0.00 0.00
0
102.36M
US$ -
US$ 0.00
-0.0003 -100.00
6,860
407.07M
US$ -
US$ 0.00
0.00 0.00
0
70.39M
US$ -
US$ 0.00
0.00 0.00
0
175.99M
US$ -

Medical Cannabis News


Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations

    New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed... Read more


    Aurora Cannabis Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

      EDMONTON, AB, June 26, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program... Read more


      Trulieve Cannabis to Open Medical Cannabis Dispensary in Oakland Park, Florida

        New Broward County location will host grand opening celebration Saturday, June 28th TALLAHASSEE, Fla., June 26, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Oakland Park, Florida. A grand opening... Read more


        Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use

          SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a significant milestone in its European expansion with the... Read more


          FLUENT Launches Wandr™ Brand and Live Rosin Edibles in New York via ENTOURAGE

            NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), operating through its ENTOURAGE wholesale group, today announced the launch of its wellness-driven brand Wandr in the New York adult-use market, alongside the debut of Wandr Live Rosin Chews, the brand’s premium, solventless edibles. The expansion of Wandr into the New York... Read more


            1933 Industries Reports Profit in Third Quarter 2025 Financial Results

              VANCOUVER, BC / ACCESS Newswire / June 16, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its third quarter financial results ("Q3 2025") for the three and nine months ended April 30, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars. The Company owns... Read more


              Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

                HERZLIYA, Israel and CALGARY, AB, June 13, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries proudly announces the third party publication of a peer-reviewed narrative review in Cureus journal titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review"... Read more


                Aurora Cannabis Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22

                   Canada's Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB, June 5, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company's subsidiary, MedReleaf... Read more


                  FLUENT Reports First Quarter 2025 Results

                    TAMPA, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the first quarter ended March 31, 2025. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary “In Q1 2025, we generated... Read more


                    Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update

                      HERZLIYA, Israel and CALGARY, AB, May 28, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its financial consolidated results for the first quarter ended March 31, 2025, and provides a corporate update on its recent... Read more


                      MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement

                        TORONTO, May 26, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has begun production on novel cannabis metered dose inhalers for the EU and the United Kingdom, made to global pharmaceutical standards and distributed... Read more


                        Tilray Medical Brings Canada’s Iconic Cannabis Brand Good Supply to Germany

                          NEUMÜNSTER, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the launch of Good Supply in... Read more


                          MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June

                            TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the removal of all conditions precedent, related to its previously-announced agreement (the “Purchase Agreement”) for the sale of MediPharm’s facility in Hope, BC, (“Hope Facility”) to Rubicon... Read more


                            FLUENT Launches KNACK Whole Flower Brand in Florida, Expanding New York Line to the Sunshine State

                              TAMPA, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, proudly announces the Florida launch of KNACK, its whole flower brand already trusted by New York consumers. Featuring a curated, rotating selection of hybrid, indica, and sativa strains in a 3.5-gram format, KNACK... Read more


                              CV Sciences Reports First Quarter 2025 Financial Results

                                SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2025. First Quarter 2025 and Recent Financial and Operating... Read more


                                MediPharm Labs Announces Strong Q1 2025 Results

                                  Achieves Positive Adjusted EBITDA(1) Revenue of $10.8 Million, an Increase of 11% over Q1 2024 87% Growth in International Medical Cannabis Revenue, Forming 55% of Total Revenue Gross Profit of $4.2 million, or 39% of Total Revenue, Improved Significantly over Q1 2024 Management to Host Conference Call / Webcast on May 14, 2025 at 10:00 am ET TORONTO, May 14, 2025 /CNW/ - MediPharm... Read more


                                  FLUENT: Introducing Entourage: A B2B Wholesale Platform Serving the New York Cannabis Market

                                    Offering a Curated Portfolio of Brands Including MOODS, MOODS Black, and KNACK NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) --  FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), announces Entourage, a new wholesale cannabis platform serving licensed retailers across New York, officially launching with a curated portfolio of trusted and emerging brands. Developed in... Read more


                                    TILT Holdings: Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe's First Handheld Liquid Inhalation Device

                                      LONDON, May 12, 2025 /CNW/ -- Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc. ("TILT") (Cboe CA: TILT) (OTCPK: TLLTF), has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation... Read more


                                      Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

                                        Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries,... Read more


                                        Tilray Medical Introduces Cannabis Edibles in Australia

                                          SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to... Read more


                                          FLUENT Reports Fourth Quarter and Full Year 2024 Results

                                            TAMPA, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2024. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary "Closing... Read more


                                            FLUENT Introduces MOODS Black to Florida Market

                                              TAMPA, Fla., April 15, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, proudly announces the launch of MOODS Black, an extension of its acclaimed MOODS lineup. Featuring cannabis-derived terpenes and high-potency cannabis oil, MOODS Black is crafted to deliver an elevated and authentic... Read more


                                              Trulieve Cannabis to Open Medical Cannabis Dispensary in St. Petersburg, Florida

                                                New Pinellas County location will host grand opening celebration Friday, April 11th TALLAHASSEE, Fla., April 9, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in St. Petersburg, Florida. A grand opening celebration... Read more


                                                Body and Mind Lynwood IL Dispensary Grand Opening and Corporate Update

                                                  Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - April 8, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") is pleased to announce the Grand Opening event at the newly opened Lynwood Illinois dispensary. "We are excited to host the Grand Opening event on April 12th at 12:00 PM at our Lynwood dispensary conveniently, located at the corners of Glenwood... Read more


                                                  Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

                                                    Innovative Chronic Pain Treatment expand IP Protection in China's US$163 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, April 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for its Chinese (CN) li... Read more


                                                    FLUENT Expands Hyer Kind Brand to the New York Market

                                                      NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, is proud to announce the launch of Hyer Kind, a cosmic voyage into the world of premium cannabis, in the state of New York. Hyer Kind’s expertly crafted live rosin-infused pre-rolls “Boosters” are now available... Read more


                                                      Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

                                                        New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency SMITHS FALLS, Ontario / Apr 02, 2025 / Business Wire / Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand... Read more


                                                        1933 Industries Reports Second Quarter 2025 Financial Results

                                                          VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ("Q2 2025") for the three and six months ended January 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars. The Company owns... Read more


                                                          MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results

                                                            Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4. TORONTO, March 31, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial... Read more


                                                            Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

                                                              HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its audited financial consolidated results for the year ended December 31, 2024. Full Year 2024 Financial Highlights... Read more

                                                              COPYRIGHT ©2025 GREEN STOCK NEWS